![]()
The Unified Clarity of The Technical Chart For Merrimack Pharmaceuticals, Inc. (MACK) Is Amazing - NY Stock News
Merrimack Pharmaceuticals, Inc. (MACK) has created a compelling message for traders in the most recent trading. That message has grown stronger as the technical chart setup has developed into a more composite picture for the stock. This is the ...altro »
SEC charges two former Ariad executives with insider trading - Boston Business Journal
One recent case was filed against Songjiang Wang, a former employee at Merrimack Pharmaceuticals, who is accused of passing tips about the Cambridge firm to an employee of another local biotech, Akebia Therapeutics. Both defendants have pled not ...altro »
Merrimack Pharmaceuticals, Inc. (MACK) noted a price change of -3.70% and Xtant Medical Holdings, Inc. (XTNT ... - Stocks Gallery
In recent trading day Merrimack Pharmaceuticals, Inc. (MACK) stock showed the move of -3.70% with the closing price of $1.30. Closing price generally refers to the last price at which a stock trades during a regular trading session. The company moved ...altro »
Target Price for Merrimack Pharmaceuticals, Inc. (MACK) now above close for Thursday - NY Stock News
Merrimack Pharmaceuticals, Inc. (MACK) has presented a rich pool of technical data in recent sessions. These are the trends we've ... Recent trading for (MACK) has highlighted key trends upon which sound decisions can be based. The levels established ...altro »
14 hedge funds buy Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) for the first time - Post Analyst
Merrimack Pharmaceuticals, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Head of Research Drummond Daryl C has sold 4,097 shares of Merrimack Pharmaceuticals, Inc. (MACK) in trading session dated ...
Merrimack Pharmaceuticals, Inc. (MACK) traded with volume of 5.36 Million shares in last trading session - StandardOracle
Merrimack Pharmaceuticals, Inc. (MACK) added 11.45% to reach $1.46 in the previous trading session. Overall, 5.36 Million shares exchanged hands versus its average trading volume of 3.71 Million shares. The relative volume of the stock is 1.44, while ...
![]()
Merrimack Pharmaceuticals, Inc. (MACK) went down -1.69% in the last trading session - HugoPress
While looking at the SMA values of Merrimack Pharmaceuticals, Inc. (MACK), the 200 simple moving average (SMA) is considered a key indicator by traders and market analysts for determining the overall long-term trend. The 200 SMA is considered so ...
Merrimack Pharmaceuticals, Inc. (MACK) Delivers Clear Picture With Technicals - NY Stock News
Merrimack Pharmaceuticals, Inc. (MACK) is now trading with a very clear set of technicals. Taken together they paint a very compelling picture of how investors and traders should be approaching MACK. Technical charts are very important tools for ...
![]()
Merrimack Pharmaceuticals, Inc. (MACK) closes -56.33% below ... - NY Stock News
Merrimack Pharmaceuticals, Inc. (MACK) is looking very interesting as a trading opportunity right now. The technical setup offers the best window into what ...altro »
![]()
Review of Price Trends: Portola Pharmaceuticals, Inc. (PTLA) and Merrimack Pharmaceuticals, Inc. (MACK) trades ... - NYSE Journal (press release)
Shares of Portola Pharmaceuticals, Inc. (PTLA) made a gain as they have increased 1.52% to end at $56.91 on Monday. Shares seen boost move of 55.92% in the past five days; the stock price is now 153.61% so far on the year — still in positive territory.altro »
